ArticlePLoS computational biology2026
MsgaBpred: A B-cell epitope predictor integrating AlphaFold3-predicted structures with multi-scale GCNs and pre-trained language model ESM-C.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of B-cell epitopes plays a key role in facilitating advancements in vaccines, therapeutics, and diagnostics. In contrast to labor-intensive experimental approaches, computational strategies provide a more economical and efficient means of identifying potential epitopes. Existing methods are often limited by their reliance on experimentally resolved protein structures or by the use of lower-accuracy predicted structures. Sequence-based approaches, while fast, largely fail to capture the 3D spatial context essential for conformational epitopes. With the breakthroughs achieved by AlphaFold3 in predicting protein structures, we present MsgaBpred, the model to apply AlphaFold3-derived structures to B-cell epitope identification. Given only a protein sequence, our model employs a multi-scale graph convolutional network and additive attention to capture complex structural dependencies without relying on experimentally determined structures. The multi-scale design allows for effective modeling of both local and global contexts by aggregating information across different neighborhood ranges. Additionally, we leverage ESM-C, a more expressive protein language model than ESM-2, to enhance feature representation for B-cell epitope prediction. Extensive evaluations across multiple benchmark datasets demonstrate that MsgaBpred achieves competitive and robust performance; notably, it yields a statistically significant improvement in AUC compared to existing state-of-the-art methods. Moreover, the modular and scalable architecture of MsgaBpred holds promise for broader applications, including the structural analysis of other biomolecular entities such as nucleic acids and carbohydrates.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.